3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Radiotherapy
4
osimertinib
3
aflutinib
3
Radiosurgery
3
Pemetrexed
3
Drug Therapy
3
Carboplatin
3
toripalimab
2
pembrolizumab
2
Docetaxel
2
tislelizumab
1
sugemalimab
1
lenvatinib
1
cemiplimab
1
brigatinib
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Surgical Procedures, Operative
1
S 1 (combination)
1
Platinum Compounds
1
Platinum
1
Pharmaceutical Preparations
1
Paclitaxel
1
Neoadjuvant Therapy
1
JDQ443
1
Immune Checkpoint Inhibitors
1
HM781-36B
1
Gemcitabine
1
Diphenhydramine
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
NSCLC
×
tipifarnib
×
1 year
×
Clear all
No trials found.